In this regard, targeted silencing of IDO in endogenous APC improves antitumor T cell function in a murine melanoma model,306 and silencing IDO in exogenous DC prior to vaccination improves T cell function and tumor control in a murine breast cancer model.307. The gene discussed is IDO1; the disease is breast carcinoma.